Archive | BioPark

Paragon Bioservices Recognized as Life Science Company of the Year by MTC

Paragon

Baltimore, MD, May 18, 2018 – Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines, was named the 2018 Life Science Company of the Year by the Maryland Tech Council (MTC). The announcement came at MTC’s 30th Annual Industry Awards held last night […]

Comments Off on Paragon Bioservices Recognized as Life Science Company of the Year by MTC Continue Reading →

UMB’s Jim Hughes Featured in BioTalk Podcast: Live from the BioHealth Capital Region Forum

BIoTalk Logo_small

During the BioHealth Capital Region Forum held last month, Jim Hughes, Vice President at University of Maryland, Baltimore, was among those interviewed for a BioTalk Podcast including select leaders from different parts of the BioHealth Capital Region discussing what they are working on, and their thoughts on the event. Jim discussed some of the recent startup successes […]

Comments Off on UMB’s Jim Hughes Featured in BioTalk Podcast: Live from the BioHealth Capital Region Forum Continue Reading →

VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark

UMBioPark-Twitter-Profile-Image

Three common disorders that are on the rise worldwide—attention deficit hyperactivity disorder (ADHD), memory loss, and cardiovascular disease—may be more manageable thanks to a growing area of research and development in “medical foods.” And VAYA Pharma, one of the newest BioPark tenants, is developing medical foods that may hold the key to better management of […]

Comments Off on VAYA Pharma, a Fast Growing Pioneer in Using Lipids to Treat Disease, Settles in UM BioPark Continue Reading →

PressComm PR’s Interview with Eddy C. Agbo of Fyodor Biotechnologies for UM BioPark

agbo

This fall we had the chance to catch up with Dr. Eddy C. Agbo, who is the Chairman and CEO of Fyodor Biotechnologies. We asked him about his company; see his answers below. Tell us about your company: Fyodor is a socially responsible biotechnology company that addresses urgent global healthcare needs in emerging economies. Fyodor […]

Comments Off on PressComm PR’s Interview with Eddy C. Agbo of Fyodor Biotechnologies for UM BioPark Continue Reading →

Technically Baltimore: Early-stage healthcare startup Advanced Metrics moves into BioPark

Photo courtesy of UMB

Via Technically Baltimore: AMS, founded in January 2013, has quickly moved to the commercialization stages of its first product, KIDnet, a real-time reporting tool that tracks the outcomes of behavioral health treatment for children and adults.

Comments Off on Technically Baltimore: Early-stage healthcare startup Advanced Metrics moves into BioPark Continue Reading →

The BioBuzz on… UM Ventures and Jim Hughes

Jim Hughes, head of UM Ventures

A year ago, James L. Hughes, M.B.A., vice president and chief enterprise and economic development officer at University of Maryland, Baltimore (UMB), was named director of University of Maryland Ventures (UM Ventures), the ambitious joint research commercialization effort of UMB and University of Maryland, College Park (UMCP), and a central part of the MPowering the State initiative. […]